MAP PHARMACEUTICALS, INC. Revenue
MAP PHARMACEUTICALS, INC. reported Revenue of $878.00 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. revenues for the quarter ending 2012-09-30 was $878.00K, a 95.79% decline year-over-year.
- MAP PHARMACEUTICALS, INC. revenues for the quarter ending 2012-06-30 was $878.00K, a 4.90% increase year-over-year.
- MAP PHARMACEUTICALS, INC. revenues for the quarter ending 2012-03-31 was $1.03M, a 84.23% increase year-over-year.
- MAP PHARMACEUTICALS, INC. revenues for the quarter ending 2011-12-31 was $837.00K.
- MAP PHARMACEUTICALS, INC. revenues for fiscal 2011 was $23.07M.
- MAP PHARMACEUTICALS, INC. revenues for fiscal 2009 was $54.17M.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 96 month | Revenues 96 month as first filed | Revenues 99 month | Revenues 99 month as first filed | Revenues 102 month | Revenues 105 month | Revenues 108 month | Revenues 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $878.00K 10-Q · filed 2012-11-06 | $1.76M derived: sum of 2 quarters · filed 2012-11-06 | $2.78M 10-Q · filed 2012-11-06 | $3.62M derived: sum of 4 quarters · filed 2012-11-06 | $80.02M 10-Q · filed 2012-11-06 | ||||||||||
| 2012-06-30 | $878.00K 10-Q · filed 2012-07-27 | $1.91M 10-Q · filed 2012-07-27 | $2.74M derived: sum of 3 quarters · filed 2012-07-27 | $23.58M derived: sum of 4 quarters · filed 2012-11-06 | $79.14M 10-Q · filed 2012-07-27 | ||||||||||
| 2012-03-31 | $1.03M 10-Q · filed 2012-05-08 | $1.86M derived: sum of 2 quarters · filed 2012-05-08 | $22.70M derived: sum of 3 quarters · filed 2012-11-06 | $23.54M derived: sum of 4 quarters · filed 2012-11-06 | $78.26M 10-Q · filed 2012-05-08 | ||||||||||
| 2011-12-31 | $837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $21.67M derived: sum of 2 quarters · filed 2012-11-06 | $22.51M derived: sum of 3 quarters · filed 2012-11-06 | $23.07M 10-K · filed 2012-03-30 | $77.23M 10-K · filed 2012-03-30 | ||||||||||
| 2011-09-30 | $20.84M 10-Q · filed 2012-11-06 | $23.86M 10-Q · filed 2011-11-08 | $21.67M derived: sum of 2 quarters · filed 2012-11-06 | $22.23M 10-Q · filed 2012-11-06 | $61.54M 10-Q · filed 2011-11-08 | $76.40M 10-Q/A · filed 2012-03-30 | $115.70M 10-Q · filed 2011-11-08 | ||||||||
| 2011-06-30 | $837.00K 10-Q · filed 2012-07-27 | $3.51M 10-Q · filed 2011-08-08 | $1.40M 10-Q · filed 2012-07-27 | $37.67M 10-Q · filed 2011-08-08 | $55.56M 10-Q/A · filed 2012-03-30 | $91.84M 10-Q · filed 2011-08-08 | |||||||||
| 2011-03-31 | $558.00K 10-Q · filed 2012-05-08 | ||||||||||||||
| 2009-12-31 | $54.17M 10-K · filed 2012-03-30 |